SAN FRANCISCO, November 28, 2016 /PRNewswire/ --
The nuclear medicine market is expectedto reach USD 13.8 billion by 2024, according to a new report by Grand View Research, Inc. The burden of chronic diseases such as cancer and cardiac disorders is on rise. Nuclear medicine products are widely used for diagnosis
(Logo: http://photos.prnewswire.com/prnh/20150105/723757 )
The increasing prevalence of these disorders poses direct impact on usage of radiopharmaceutical market. For instance, as per the data published by the World Health Organization (WHO), the incidences of cancer are anticipated to increase by 70.0% which is further anticipated to drive the demand for radiopharmaceuticals.
The diagnostics when combined with nuclear medicine improve on accuracy. The accuracy in the diagnosis has a direct impact on the decision-making and treatment monitoring process. Adoption of PET as a diagnostic tool is rapidly increasing since it has high accuracy over other diagnostic techniques.
Browse full research report with TOC on "Nuclear Medicine Market Analysis By Application (Diagnostics: Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Therapeutics: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumor) Segment Forecasts, 2013 - 2024" at: http://www.grandviewresearch.com/industry-analysis/nuclear-medicines-market
Further key findings from the study suggest:
Browse related reports by Grand View Research:
Grand View Research has segmented the global nuclear medicine market on the basis of product and region:
Access research insight: http://www.grandviewresearch.com/research-insights/nuclear-medicine-market-emerging-technology
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Read Our Blogs - http://www.grandviewresearch.com/blogs/healthcare
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected]
SOURCE Grand View Research, Inc.
Subscribe to our Free Newsletters!
Sea food allergy is the adverse response of the body''s immune system to the proteins present in ...
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...View All